Introduction {#S1}
============

The coordinated and accurate segregation of paired chromatids is critical to somatic cell division in mitosis and the genesis of germ cells in meiosis. Timely disjunction of coherent chromatids is achieved through removal of centromeric cohesin mediated by the separase-catalysed proteolysis of the kleisin subunit of cohesin complexes [@R1]--[@R3]. Accurate chromatid disjunction is crucial to prevent chromosome missegregation that contributes to aneuploidy and tumourigenesis [@R4],[@R5]. To ensure genome stability, separase activity is tightly regulated by binding to its inhibitory chaperone securin [@R6]--[@R8], a natively unfolded protein [@R9],[@R10] that is present in excess over separase in the cell and associates with separase during translation [@R6]--[@R8],[@R11]. Paradoxically, in addition to its inhibitory function, securin plays an important role in promoting separase activity [@R12]--[@R14]. This likely results from stabilizing effects, since securin deficient human HCT116 cells exhibit a roughly four-fold reduction in separase levels [@R12] and conversely, overexpression of separase results in elevated levels of securin [@R15]. Stabilizing effects of securin are also observed in other species including the separase-securin complex from *Caenorhabditis elegans* [@R16]. In vertebrates a small proportion is also inhibited through CDK-cyclin B1-dependent phosphorylation and binding [@R15],[@R17],[@R18]. Separase activation is triggered by the anaphase-promoting complex (APC/C)-dependent ubiquitin-mediated proteolysis of securin and cyclin B1 (refs [@R19]--[@R21]).

Separase is a caspase-family protease comprising a C-terminal separase protease domain (SPD) with specificity for cleaving substrates C-terminal to an Arg residue (P1) within an (S/D)xExxR motif [@R3],[@R7],[@R22]. In budding yeast, polo kinase-dependent phosphorylation of Scc1 (Pds1) at the Ser residue at P6 regulates Scc1 cleavage and thus sister chromatid separation [@R23]. A large N-terminal domain contributes to securin and substrate interactions [@R14],[@R22],[@R24]. Crystallographic studies of the separase protease domain (SPD) with inhibitory peptides explained the basis for substrate selection [@R25], however the molecular mechanisms underlying separase regulation have not yet been defined. To understand the dual mechanisms of activation and repression of separase activity by securin we used single particle cryo-EM to determine a near-atomic resolution structure of the *C. elegans* separase-securin complex. We also determined a medium resolution reconstruction of the human separase-securin complex, revealing the evolutionary conservation of separase's triangular shape.

This study provides insights into the overall architecture of separase, explains the substrate-occlusion inhibitory mechanism of securin and rationalizes the strict necessity of an arginine residue in the P1 binding pocket to mediate substrate-assisted cleavage. We also demonstrate the applicability of cryo-EM to resolve structures of macromolecules of \~150 kDa that are difficult to crystallize.

Results {#S2}
=======

Cryo-EM structure of a separase-securin complex at 3.8 Å resolution {#S3}
-------------------------------------------------------------------

To optimize the contrast of a relatively small complex in cryo-electron micrographs, and to overcome preferred molecule orientations of this complex encountered in vitreous ice, we used graphene oxide coated EM grids [@R26] ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). We determined a reconstruction of the asymmetric separase-securin complex at 3.8 Å resolution ([Fig. 1](#F1){ref-type="fig"} and [Supplementary Figs 1 and 2](#SD1){ref-type="supplementary-material"}). Most of the complex, particularly the larger separase subunit, was well defined in EM density. Side-chain density was unambiguously assigned for more than 95% of all structured amino acid allowing complete *ab initio* model building of separase. Securin, which forms an extended structure that interacts mainly with the periphery of separase, was well resolved around the substrate-binding site but less well-defined elsewhere ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"} and [Table 1](#T1){ref-type="table"}).

Overall architecture of the *C. elegans* separase-securin complex {#S4}
-----------------------------------------------------------------

The *C. elegans* separase-securin adopts a triangular-shaped bilobal architecture, measuring 110 Å in its longest dimension and about 70 Å in its two other dimensions. Separase is composed of an N-terminal α-solenoid domain adjoined to the C-terminal separase protease domain (SPD) [@R25] ([Fig. 1](#F1){ref-type="fig"}). A clearly defined cleft is situated at the interface of these two domains. The α-solenoid domain comprises 25 α-helices, mainly arranged as a right-handed superhelix that resembles a tetratricopeptide repeat (TPR) superhelix, as predicted [@R27]. Compared to a canonical TPR superhelix however, compression of the helix and the irregular length of its constituent α-helices create a compact globular structure lacking the deep surface grooves typical of TPR proteins ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). The C-terminus of the α-solenoid interacts with the SPD, whereas its N-terminus is capped by securin, possibly explaining how securin contributes to separase stability [@R12]--[@R14] ([Figs 1b](#F1){ref-type="fig"} and [2a](#F2){ref-type="fig"}). The α-solenoid domain accommodates two disordered insertions. Insert-1 includes the site of regulatory CDK-phosphorylation of human separase [@R17],[@R28], whereas insert-2 incorporates the auto-cleavage sites [@R2],[@R29],[@R30] and cyclin B1 (refs [@R15],[@R18]) and PP2A [@R31] binding sites of vertebrate separase ([Fig. 1](#F1){ref-type="fig"} and [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). Both inserts project towards the separase catalytic site, located within reach of the tips of both inserts ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 4a, b](#SD1){ref-type="supplementary-material"}). Insert-2 of human separase is markedly longer than its counterpart in *C. elegans* separase, such that all three auto-cleavage sites are accessible to the catalytic site. The marked positive electrostatic potential on one surface of separase ([Fig. 1c](#F1){ref-type="fig"}) might be related to its activation by DNA [@R32] and the stimulation of Rec8 cleavage in meiosis by multisite phosphorylation of Rec8, facilitating high affinity binding of the substrate [@R27].

The SPD of *C. elegans* separase, like *Chaetomium thermophilum* SPD (*Ct*SPD) [@R25], is divided into two sub-domains, one of which is the C-terminal active protease domain (APD) ([Fig. 1a, b](#F1){ref-type="fig"} and [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). APD belongs to the caspase/gingipain family of cysteine proteases and incorporates an essential Cys-His catalytic dyad [@R1],[@R17],[@R33]. The APD comprises a central β-sheet flanked on both sides by α-helices ([Fig. 1b](#F1){ref-type="fig"}). The adjacent pseudoprotease domain (PPD) extends the APD β-sheet, reminiscent of the architecture of caspase dimers formed from active and inactive catalytic subunits [@R33]. An α-helical insertion within the PPD stretches out over the PPD and APD, forming extensive contacts with the APD ([Fig. 1b](#F1){ref-type="fig"}, right panel). This long α-helical insertion is indispensible for protease activity, presumably due to its roles in substrate recognition, as discussed below, and in contributing to the structural integrity of the protein [@R25]. It is followed by a four-helix bundle, which forms at the periphery of the APD ([Fig. 1b](#F1){ref-type="fig"}, left panel).

Loop L4 conformation is constrained in the full-length protein {#S5}
--------------------------------------------------------------

The SPD of the *C. elegans* separase-securin complex and *Ct*SPD [@R25] superimpose closely with an RMSD of 3.5 Å over 365 Cα-atoms and 1.6 Å over 121 Cα-atoms for the APD ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). The four-helix bundle is shifted in the *C. elegans* structure towards the N-terminus of the molecule by 9 Å and rotated by 7°. His1014^Sep^ and Cys1040^Sep^ of the catalytic dyad are located in loops L3 and L4, respectively (separase and securin residues are denoted with superscript 'Sep' and 'Sec'). Caspases are regulated by the conformation of the L4 loop [@R33], and in the context of the securin-separase complex, the L4 loop adopts an active conformation, although the position of its tip differs from its counterpart in *Ct*SPD [@R25] ([Fig. 2d](#F2){ref-type="fig"}).

The C-terminus of the α-solenoid domain is capped by the SPD. An extensive hydrophobic interface is created primarily by the H23 and H24 α-helices of the α-solenoid docking onto the central β-sheet of the PPD ([Fig. 1b](#F1){ref-type="fig"}). Its large size suggests a stable interaction. The tip of the L4 loop projects into the groove of the α-solenoid superhelix ([Fig. 2a, b](#F2){ref-type="fig"}). Phe1052^Sep^, a conserved hydrophobic residue in separase ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}), is located at the tip of L4 and is buried within a hydrophobic pocket of the α-solenoid domain ([Fig. 2c](#F2){ref-type="fig"}). Mutations of the L4 loop in *Ct*SPD modulate Scc1 cleavage rates [@R25], showing that the conformation of the L4 loop contributes slightly to catalytic activity.

Securin acts as a non-cleavable pseudo-substrate {#S6}
------------------------------------------------

Securin is an intrinsically disordered protein [@R9],[@R10] that functions as an inhibitory chaperone to both stabilize separase [@R12]--[@R14], and through a pseudo-substrate mechanism, inhibit protease activity [@R14],[@R29]. Our structure shows that bound to separase, securin forms an extended conformation interacting along the entire length of separase in an anti-parallel orientation ([Fig. 1b, c](#F1){ref-type="fig"}). The N-terminal 116 residues, including the APC/C degron recognition and ubiquitination sites are unstructured ([Fig. 1a](#F1){ref-type="fig"}). The separase-binding motif (SBM) encompasses residues 118-199 and is part of a previously identified inhibitory segment of securin [@R34] that is evolutionarily well conserved ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). The N-terminus of the SBM blocks the separase catalytic site filling a 16 Å-wide cleft between the α-solenoid domain and the SPD ([Figs 1](#F1){ref-type="fig"} and [2c](#F2){ref-type="fig"}). SBM's C-terminus curls along a hydrophobic path on the outside of the α-solenoid domain, with two short α-helices anchored within adjacent hydrophobic grooves ([Figs 1b, c](#F1){ref-type="fig"} and [2a](#F2){ref-type="fig"}). This is in agreement with biochemical studies indicating that the C-terminus of securin contacts the α-solenoid domain of separase [@R14],[@R24]. A C-terminal fragment of the Scc1 substrate remains bound to separase even in the absence of the cleavage site residues [@R22], indicating the importance of the N-terminal α-solenoid domain in conferring high affinity binding to both substrate and inhibitor.

Separase substrates share a common \[D/E/S\]xExxR motif (positions P6 to P1), and are cleaved immediately C-terminal to the P1 Arg residue [@R3],[@R7],[@R22] ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). Polo kinase-phosphorylation of yeast Scc1 at the P6 serine stimulates separase cleavage [@R23]. A DIExxΦ motif in securin mimics substrate recognition with the P1 Arg substituted by a hydrophobic residue (Met126^Sec^ in *C. elegans* securin) [@R34] ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). Notably, the P1 Arg of separase substrates is critical for cleavage [@R7],[@R22],[@R35]--[@R37]. Replacing Arg with Ala, Asp or Glu eliminates proteolysis [@R3],[@R7],[@R13],[@R22], whereas conversely the securin pseudo-substrate motif is cleaved when an Arg is substituted for the hydrophobic residue at its P1-binding pocket [@R25],[@R34].

Our structure reveals that the mode of interaction of the securin pseudo-substrate motif with *Ce* separase is remarkably similar to the interactions between the *Ct*SPD and a covalently linked peptide mimicking Scc1 ([Fig. 3a, b](#F3){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}) [@R25]. This confirms the concept that securin acts as a pseudo-substrate inhibitor [@R14],[@R29],[@R34], and importantly indicates that in the inhibited *Ce* separase-securin complex, the separase catalytic site architecture adopts a conformation compatible with substrate recognition. In the *Ce* separase-securin complex, Ile122^Sec^ (P5) forms hydrophobic interactions with Phe783^Sep^, a strictly conserved aromatic residue of the α-helical insert ([Fig. 3c](#F3){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). This interaction rationalizes the strong conservation of residues with non-polar character at the P5 site of separase substrates ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). Glu123^Sec^ at P4 forms electrostatic interactions with the highly conserved Arg1083^Sep^, mimicking Scc1-*Ct*SPD interactions [@R25]. Amino acid side chains at variable positions P3 and P1' ([@R22]) are solvent exposed. C-terminal to the pseudo-substrate motif, securin inserts into the cleft separating the SPD and α-solenoid domain, contacting the L4 loop ([Fig. 2a, c](#F2){ref-type="fig"}).

Similarly to the P1 Arg of the Scc1-peptide bound to *Ct*SPD [@R25], Met126^Sec^ is anchored by the P1-binding pocket of *Ce* separase ([Fig. 3c-e](#F3){ref-type="fig"}). This deep pocket is lined by a mixture of conserved hydrophobic and polar residues including His1014^Sep^ of the catalytic dyad ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Through conformational flexibility, the P1 pocket accommodates both non-polar residues of securin and the P1 Arg residue of separase substrates ([Fig. 3d, e](#F3){ref-type="fig"} and [Supplementary Video 1](#SD2){ref-type="supplementary-material"}). Importantly, the interactions of an Arg side chain at the P1 pocket organize the configuration of catalytic site residues required for peptide cleavage. In the *Ct*SPD structure, the invariant Asp2151 residue, equivalent to Asp1082^Sep^ that is rotated out of the P1-binding pocket in *Ce* separase, forms a stable bi-dentate salt-bridge with the substrate P1 Arg guanidinium group [@R25] ([Fig. 3e](#F3){ref-type="fig"}). This interaction allows the Nε atom of the P1 Arg guanidinium group to donate a hydrogen bond to the main chain carbonyl of Gly2082^Sep^ that orients the catalytic His2083^Sep^ side chain to create the oxyanion hole for the carbonyl oxygen at P1 ([Fig. 3e](#F3){ref-type="fig"}). In the *Ce* separase-securin complex, the P1-binding pocket widens to accommodate the non-polar Met126^Sec^ side chain. Relative to their counterparts in *Ct*SPD, Gly1013^Sep^ and the imidazole ring of His1014^Sep^ move away from Met126^Sec^ by almost 2 Å ([Fig. 3d](#F3){ref-type="fig"} and [Supplementary Fig. 8a versus b](#SD1){ref-type="supplementary-material"}). Thus, an Arg at P1 functions to mediate catalysis by orienting the catalytic His to create the oxyanion hole, necessary for cleavage of the scissile bond [@R1],[@R17].

The triangular shape of separase is conserved throughout evolution {#S7}
------------------------------------------------------------------

Although the SPD is conserved across eukaryotes ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}), sequence similarities within the α-solenoid domain are difficult to discern ([Supplementary Fig. 4c](#SD1){ref-type="supplementary-material"}). However, the triangular shape of separase-securin is evolutionarily conserved because the structure of *C. elegans* separase-securin is similar to a medium resolution cryo-EM reconstruction of human complex we determined ([Fig. 4a, b](#F4){ref-type="fig"} and [Supplementary Fig 1](#SD1){ref-type="supplementary-material"}), and consistent with a previous negative stain EM reconstruction [@R24]. *C. elegans* separase-securin resembles the 'whale'-like domain described in the human separase-securin structure [@R24]. The flexible 'tail'-like feature at the N-terminus of human separase-securin is not present in our structure of the *C. elegans* complex. This likely represents the N-terminal 650 residues of human separase [@R27] absent from *C. elegans* ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). A recently reported EM structure of *C. elegans* separase-securin complex at 24 Å resolution [@R16] revealed a bi-lobal architecture that has similar overall dimensions and is generally compatible with our cryo-EM structure, despite the lower resolution and use of negative stain.

Discussion {#S8}
==========

The role of the substrate Arg P1 residue that participates in organizing the catalytic site is reminiscent of other enzymes that derive specificity through substrate-assisted catalysis [@R38],[@R39]. It explains the requirement for an Arg at P1 for substrate cleavage [@R3],[@R7],[@R22] and why securin is capable of engaging the separase substrate-binding site, competing with Scc1, without itself being cleaved [@R22]. Thus, securin inhibits separase through a competitive mechanism that interferes with substrate recognition, and represses its intrinsic protease activity through small conformational rearrangements of its catalytic site. This inhibition mechanism contrasts with XIAP inhibition of caspases which block access to the substrate-binding cleft by binding in the reverse orientation [@R40],[@R41].

Here we reveal how securin inhibits separase through a substrate occlusion mechanism. Additionally, securin destruction and its displacement from the TPR lobe may promote a conformational change of separase affecting the catalytic site and L4 loop that stimulates catalytic activity. Future structural studies of securin-free separase are required to address this question and also to understand other regulatory mechanisms including the mutually exclusive CDK1-cyclin B1 dependent repression of vertebrate separase that involves a phospho-dependent Pin1-catalysed peptidyl prolyl *cis/trans*-isomerization [@R28] leading to cyclin B1 association and separase inhibition.

Mutations, overexpression or mislocalization of separase leads to elevated tumour development [@R42],[@R43], and hence inhibition of separase is a tempting pharmacological target. This structure will provide a rational molecular basis for the design of small molecule drug targets to inhibit uncontrolled separase activity in certain cancer types.

Online Methods {#S10}
==============

Cloning and expression of *Caenorabditis elegans* and *Homo sapiens* separase-securin complex genes {#S11}
---------------------------------------------------------------------------------------------------

The cDNAs encoding for the *Caenorabditis elegans*, *Homo sapiens* and *Chaetomium thermophilum* separase and securin genes were ordered as gene optimized versions for expression in insect cells, and synthesized cDNAs (GeneArts /Thermo Fisher) were subsequently cloned into pU1 (separase) and pF1 (securin) vectors [@R44]. A double StrepII-tag followed by a TEV (tobacco etch virus) site was fused N-terminal of the separase gene. An N-terminal truncation of 139 residues of *Ce* securin was generated using mutagenesis PCR, and a TEV-cleavable MBP tag was added C-terminal to securin in the human construct. *Chaetomium thermophilum* separase and the *C. thermophilum* separase-securin complex were generated with the auto-cleavage site E1643R/R1646E mutant in separase. A *C. thermophilum* separase-securin complex with an N-terminal 180 residue truncation of securin was generated by mutagenesis PCR. The resultant plasmids were transformed into MultiBacDH10α cre cells to generate bacmids through *in vivo* recombination [@R44]. A single recombinant vector was used for recombinant baculovirus generation.

Separase-securin overexpression {#S12}
-------------------------------

Recombinant P3 baculoviruses were used for infection of High Five insect cells (Invitrogen) at a cell density of roughly 2.0 x 10^6^ cells per ml. The cells were incubated for 72 hours at 27 °C at 150 rev./min, harvested at a cell viability rate of \~80%, flash-frozen in liquid nitrogen and stored at -80 °C.

Purification of separase-securin complexes {#S13}
------------------------------------------

Purification of the protein complexes were performed at 4 °C. Cells were resuspended in lysis buffer \[50 mM Tris/HCl (pH 8.3), 250 mM NaCl, 1 mM EDTA, 1 mM DTT, Protease inhibitor cocktail tablets (PIC) (Complete EDTA-free; Roche Diagnostics GmbH), 0.1 mM PMSF, 5 units/ml benzonase (Novagen)\], subsequently sonicated and centrifuged for 1 h at 48,000 g. The soluble fraction was slowly (1 ml/min flow rate) applied to a 5 ml StrepTactin Superflow Cartridge (Qiagen) and washed with wash buffer (lysis buffer without PIC, PMSF and benzonase) until stable UV absorption could be observed. Peak fractions were incubated with TEV protease at 4 °C overnight and wash buffer without NaCl (buffer A) was used for a two-fold dilution before loading onto a ResourceQ anion-exchange column (GE Healthcare) the next day. After a washing step the complexes were eluted using a gradient with buffer B \[20 mM Tris/HCl (pH 8.0), 1 M NaCl, 1 mM DTT\]. A final size exclusion step on a Superose 6 Increase 10/300 GL column with 20 mM Hepes-NaOH (pH 7.8), 200 mM NaCl and 1 mM DTT was performed.

Preparation of graphene oxide support covered grids {#S14}
---------------------------------------------------

Graphene oxide dispersion (Sigma-Aldrich; 2 mg/mL in H~2~O) was diluted ten-fold with ddH~2~O to a final concentration of 0.2 mg/ml and subsequently spun down at 300g for \~15 sec to remove large aggregates of graphene oxide flakes (pellet formation could be observed occasionally) \[as described in [@R26]\]. After incubation for one minute with graphene oxide dispersion, Quantifoil grids were glow discharged for one minute utilizing a Edwards Sputter Coater S150B. After incubation the graphene oxide solution was removed by blotting briefly with Whatman No.1 filter paper and washed by absorbing 20 μl ddH~2~O onto the graphene oxide coated side twice and once on the back side of the grid with blotting steps in between (for detailed video and protocol see <https://figshare.com/articles/Graphene_Oxide_Grid_Preparation/3178669>). The tendency of biological molecules to adopt preferred orientations in thin vitreous ice likely results from interactions at the hydrophobic air-water interface. Presumably these interactions favour the largest exposed hydrophobic surface and thus select specific orientations of the molecule. Immobilizing the sample to a carbon, graphene or graphene oxide support substrate reduces interactions at the air-water interface. In contrast to the air-water interface, graphene oxide is hydrophilic, and thus will interact with different surfaces of separase-securin, promoting different orientations.

Electron microscopy data collection {#S15}
-----------------------------------

Purified separase-securin complexes from *C. elegans* and human were applied to graphene oxide covered gold 300 square mesh Quantifoil R1.2/1.3 holey-carbon grids (Quantifoil Micro Tools GmbH) at a concentration of \~100 nM (waiting time 30s, blotting time 8s) and flash frozen in liquid ethane using a custom fabricated manual plunger at 4 °C. *C. elegans* separase specimens were specimens were imaged manually on an FEI Titan Krios electron microscope operating at 300 kV accelerating voltage. Zero-energy-loss micrographs were recorded using a Gatan K2-Summit direct electron detector executed in super-resolution counting mode at the end of a Gatan GIF-Quantum energy filter with a slit width of 20 eV. The calibrated magnification was 34,965 corresponding to a pixel size of 1.43 Å and images were collected at a dose rate of \~2.5 electrons/Å^2^/s. Exposures of 16 seconds were dose-fractionated into 20 movie frames with a total dose of \~40 electrons per Å^2^. Defocus values in the final data set ranged from -1.0 to -3.3 μm. Automated data acquisition applying the same exposure time and total dose as described for the *C. elegans* separase-securin complex was used for data collection of the human separase-securin complex at Diamond Light Source (DLS) with a calibrated magnification of 47,619 that corresponds to a pixel size of 1.05 Å.

Image processing {#S16}
----------------

Super resolution micrograph movies with a pixel size of 0.715 Å were binned to 1.43 Å. Micrograph movie frame stacks were first aligned using MOTIONCORR [@R45] before further processing. The contrast transfer function (CTF) parameters were determined using GCTF [@R46] and RELION [@R47] was used for most other image processing steps. Initial particle picking was performed using e2boxer.py in EMAN2 ([@R48]) employing only a subset of the data set and particles were extracted applying a 180 pixel \* 180 pixel box. Reference-free 2D classification yielded into initial 2D classes that were subsequently used as references (low-pass filter of 20 Å was applied to avoid reference bias) for automatic particle picking [@R49]. A high-pass filter of 400 Å with a 50 Å width of the raised cosine on the high-pass filter edge was applied to all micrographs to correct for the ice gradient present on most of the micrographs in order to reduce false positive picking of particles. In total 2.4 million particles were picked from 2,793 micrographs and extracted from original unmodified micrographs. Reiterative reference-free two-dimensional class averaging and strict selection of classes that showed distinct/strong structural features resulted into a particle subset of 665,331 particles. An *ab initio* 3D reconstruction was created using SIMPLE-PRIME [@R50] and used as an initial model for a first 3D refinement. Correction of beam-induced motion of individual particles and B-factor weighting of single frames to treat radiation damage problems were performed in the particle polishing step [@R51] in RELION. Auto-refinement of polished particles with a soft mask (with 5-pixel fall-off) around the entire molecule led to a density map of 4.2 Å resolution. This particle subset was subjected to two rounds of three-dimensional classifications to separate structural heterogeneity and dispose of remaining bad particles (see [Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). In a final step all micrographs with a resolution lower than 4.0 Å according to the resolution estimation of GCTF were discarded, which resulted in a final data set of 103,696 particles that refined to a map with the resolution of 3.8 Å. All resolution estimations are derived from Fourier shell correlation (FSC) calculations between reconstructions from two independently refined half-sets and reported resolutions are based on the FSC = 0.143 criterion [@R52],[@R53]. Local resolution was estimated using ResMap [@R54]. Images collected at the DLS were collected in counting mode and processed as described for the *C. elegans* data set with the exception of a 240 \* 240 pixel box size due to larger particle size. Auto-refinement of particles with a soft mask (with 5-pixel fall-off) around the entire molecule led to a density map of 6.8 Å resolution. This resolution estimation is likely overestimated due to the strong preferred orientation of particles.

Model building and refinement of the *Ce* separase-securin complex {#S17}
------------------------------------------------------------------

*Ab initio* modeling of the entire *Ce* separase-securin complex was performed in COOT [@R55]. A recently published crystal structure of the C-terminal lobe of the *Chaetomium thermophilum* separase [@R25] was fitted into the density using Chimera [@R56] and used as a template and validation tool for modeling the SPD. The final model of separase lacks the N-terminal ten residues, two long unstructured loop regions (insert-1 and insert-2) present in the α-solenoid domain (residues 391-446 and residues 590-626) as well as the C-terminal 122 residues that are predicted to be unstructured and for which no density could be observed. The model was refined using Refmac v.5.8 ([@R57]) with a weight and PHENIX [@R58]. Secondary structure restrains were created by PROSMART [@R59].

Structure-based sequence alignment of separase TPR domains {#S18}
----------------------------------------------------------

The N-terminal sequence of human separase (residues 1 to 1692, N-terminal to the separase protease domain) was analysed for predicted secondary structure elements and disordered regions using PHYRE2 [@R60]. This indicated an α-helical segment interspersed with two predicted disordered regions (residues 1070-1040 and 1307-1561). The positions of these two disordered regions approximately matched Insert-1 and Insert-2 of *C. elegans* separase (390-442 and 597-618). Residues 1-390 of *C. elegans* separase were aligned with residues 651-1070 of human separase, based on matching predicted α-helices of human separase with observed α-helices of *C. elegans* separase and also guided by a published multiple sequence alignment of part of the N-terminal domain of separase [@R27]. Residues 442-597 and 618-700 of *C. elegans* separase aligned with residues 1140-1307 and 1561-1641 of human separase, respectively.
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======================
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![Overview of the *C. elegans* separase-securin complex.\
**a,** Schematic of separase and securin**. b,** Two views of the separase-securin complex. The catalytic dyad of His1014 and Cys1040, and L4 loop indicate the catalytic site. The positions of Insert-1 and Insert-2 relative to the catalytic site (corresponding to the Cα-atom of the P1 Met of securin) are indicated as spheres. Distances between the insert boundaries and the Cα-atom of the P1 residue of securin (Met126^Sec^) are shown. **c**, Two views of the molecular surface of separase showing electrostatic potential, with securin in stick representation. The positively charged surface is indicated (left).](emss-71447-f001){#F1}

![The α-solenoid domain stabilizes the L4 loop.\
**a**, Overview of separase-securin showing the molecular surface of the separase α-solenoid domain. **b,** Details of the L4 loop interactions with the α-solenoid domain. **c,** View of the L4 loop docking into the L4-loop binding pocket of the α-solenoid domain shown as a hydrophobic surface colour-ramped from white to green with increasing hydrophobicity. **d,** The L4 loops of *Ce*SPD and *Ct*SPD adopt an active conformation, with differences confined to the tip of the loop. Securin contacts the L4 loop.](emss-71447-f002){#F2}

![The interactions of the securin pseudo-substrate motif with separase resemble Scc1.\
**a**, Securin pseudo-substrate motif at the *Ce*SPD. **b**, Scc1-mimicking peptide at *Ct*SPD [@R25]. **c**, The molecular surface of *Ce* separase showing the securin pseudo-substrate sequence engaging the peptide-substrate binding site of separase. **d**, Details of the Met126(P1) residue at the P1-binding site and its corresponding EM density. **e**, P1 Arg of the Scc1-mimicking peptide at the P1-site of *Ct*SPD showing the oxyanion hole formed from the catalytic His2083 (from ref. [@R25]). The guanidinium side chain of the P1-Arg residue donates a hydrogen bond to the main-chain carbonyl of Gly2082, positioning the imidazole side chain of His2083 to create the oxyanion hole and donate a hydrogen bond to the main-chain carbonyl of Arg(P1). In contrast, Met126(P1) of *C. elegans* Scc1 widens the P1-binding pocket *C. elegans* separase such that the main-chain of Gly1012 and side chain of His1014 (equivalent to Gly2082 and His2083, respectively of *Ct*SPD) are displaced by \~2 Å.](emss-71447-f003){#F3}

![Cryo-EM reconstruction of human separase-securin complex.\
**a** and **b**, Two views showing the cryo-EM density as a transparent molecular envelop with the coordinates of *C. elegans* separase-securin fitted to the map as a rigid body. Colour-code according to [Fig. 1](#F1){ref-type="fig"}.](emss-71447-f004){#F4}

###### EM data collection and processing and structure refinement statistics.

  -------------------------------------------------------------------------------------------------------------------
                                      *Ce*Separase-securin\                                   *Hs*Separase-securin\
                                      (EMD-3583, PDB 5MZ6)                                    (EMD-3584)
  ----------------------------------- ------------------------------------------------------- -----------------------
  **Data collection**                                                                         

     Microscope                       FEI Titan Krios                                         FEI Titan Krios

     Voltage (kV)                     300                                                     300

     Electron dose (e Å ^-2^)         40                                                      40

     Detector                         Gatan K2 Summit                                         Gatan K2 Summit

     Pixel size (Å)                   1.43                                                    1.05

     Defocus Range (μm)               1.0-3.0                                                 1.0-3.0

  **Reconstruction (Relion)**                                                                 

     Particles                        103,696                                                 152,374

     Box size (pix)                   180                                                     240

     Accuracy of rotations (°)        1.960                                                   3.283

     Accuracy of translations (pix)   0.492                                                   1.994

     Map sharpening B-factor (Å^2^)   -130                                                    

     Final resolution (Å)             3.8                                                     6.8

  **Model composition**                                                                       

     Protein residues                 1097                                                    

  **Refinement**                                                                              

     Resolution (Å)                   3.8                                                     

     FSC~average~                     0.82                                                    

     R factor                         36.53                                                   

  **R.m.s deviations**                                                                        

     Bond lengths (Å)                 0.007                                                   

     Bong angles (°)                  1.012                                                   

  **Validation^2^**                                                                           

     Clashscore, all atoms            11.12                                                   

     Rotamer outliers (%)             0.57                                                    

  **Ramachandran plot**                                                                       

     Favoured (%)                     93.73                                                   

     Allowed (%)                      6.09                                                    

     Outliers (%)                     0.18                                                    

  **Disordered regions**                                                                      

  Separase                            1-10, 391-446, 590-628, 894-899, 1095-1104, 1141-1262   

  Securin                             1-117, 193-244                                          

  **Side chains fitted (%)**                                                                  

  Separase (of ordered region)        96.3                                                    

  Securin (of ordered region)         84                                                      
  -------------------------------------------------------------------------------------------------------------------
